INTERMOLECULAR INC (IMI) [Rocket]

Overview

INTERMOLECULAR INC (IMI)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
09/30/2019	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
09/24/2019	4	MARTIN WILLIAM C (10% Owner) has filed a Form 4 on INTERMOLECULAR INC
09/24/2019	SC 13D/A	Raging Capital Management, LLC reports a 0% stake in Intermolecular, Inc.
09/23/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/23/2019	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11
Revenues	33.7	37.2	47.3	45.3	47.7	67.4	66.8	53.8
Revenue growth	-9.5%	-21.3%	4.4%	-5.0%	-29.2%	0.9%	24.1%	26.1%
Cost of goods sold	10.0	12.1	16.0	19.6	24.9	32.7	28.7	26.2
Gross profit	23.7	25.1	31.3	25.7	22.8	34.7	38.1	27.6
Gross margin	70.3%	67.5%	66.3%	56.7%	47.7%	51.4%	57.1%	51.3%
Sales and marketing	3.3	4.0	7.4	5.9	5.8	6.5	5.4	4.3
Research and development	17.2	21.5	28.1	28.6	24.3	24.5	21.8	19.3
General and administrative	7.5	9.2	10.7	12.3	12.6	12.0	10.9	8.5
EBITA	-4.1	-9.3	-14.3	-19.7	-19.0	-7.4	0.9	-3.6
EBITA margin	-12.3%	-25.1%	-30.2%	-43.5%	-39.8%	-11.0%	1.3%	-6.8%
Amortization of intangibles	0.2	0.3	0.5	1.0	0.7	0.6	0.6	0.1
EBIT	-4.3	-9.7	-14.8	-20.7	-19.7	-8.0	0.3	-3.7
EBIT margin	-12.9%	-25.9%	-31.2%	-45.7%	-41.3%	-11.9%	0.4%	-6.9%
Pre-tax income	-3.4	-10.4	-15.4	-21.0	-21.8	-8.8	-0.7	-30.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Net income	-3.4	-10.4	-15.4	-21.0	-21.8	-8.8	-0.8	-38.7
Net margin	-10.1%	-28.0%	-32.6%	-46.4%	-45.6%	-13.1%	-1.1%	-71.8%

Diluted EPS	($0.07)	($0.21)	($0.31)	($0.44)	($0.47)	($0.20)	($0.02)	($3.99)
Shares outstanding (diluted)	49.7	49.5	49.4	48.2	46.7	45.0	43.0	9.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.